U.S. Markets open in 3 hrs 10 mins

Can Last Year's Biggest Vaccine Stocks Crush the Market Again?

·6 min read
Can Last Year's Biggest Vaccine Stocks Crush the Market Again?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Coronavirus vaccine stocks were the biggest investment theme of 2020. Since, two biotech companies -- Moderna (NASDAQ: MRNA) and BioNTech -- actually have commercialized their vaccines. Let's take a look at where they're at with vaccine programs -- and whether they're on track to beat the market in the second half.